Purpose: To report a rare presentation of the pericentral pattern of hydroxychloroquine (HCQ) retinal toxicity in a Caucasian female. Observations: The patient presented with 20 years of exposure to HCQ, at a daily dose of 5.2mg/kg of actual body weight, and manifested a pericentral-only phenotype of HCQ toxicity, as demonstrated with detailed structural and functional testing. Conclusions and importance: Although rare, the pericentral pattern of HCQ toxicity may occur in Caucasian patients in the absence of paracentral changes
Two patients with dermatological conditions developed retinal toxicity after treatment with hydroxyc...
Hydroxychloroquine (HCQ) in recent times has been used in treatment for a variety of autoimmune dise...
Retinal toxicity from hydroxychloroquine (HCQ) can be detected most readily on fundus autofluorescen...
PurposeA pericentral pattern of hydroxychloroquine (HCQ) retinopathy recently has been recognized in...
Background and Purpose: Occular toxicity is one of the most important complications of Hydroxychloro...
PURPOSE Hydroxychloroquine (HCQ) can cause irreversible damage to the retina, especially when taken...
Purpose The aim of this case series is to raise awareness of the emerging issue of serious retinal d...
Purpose To identify risk factors and state demographics of a cohort of patients from upper Egypt exp...
Purpose: To report an unusual fundus autofluorescence aspect in a patient with suspected hydroxychlo...
We report an unusual case of hydroxychloroquine (HCQ) toxicity after only 2 months of starting the t...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Purpose: To describe a case of hydroxychloroquine retinopathy combined with retinal pigment epitheli...
Hydroxychloroquine (HCQ; Plaquenil) is used increasingly in the management of a variety of autoimmun...
Abstract Hydroxychloroquine is widely used by rheumatologists for the treatment of various diseases,...
Hydroxychloroquine (HCQ) ocular toxicity is rare but severe, and progression can occur even after te...
Two patients with dermatological conditions developed retinal toxicity after treatment with hydroxyc...
Hydroxychloroquine (HCQ) in recent times has been used in treatment for a variety of autoimmune dise...
Retinal toxicity from hydroxychloroquine (HCQ) can be detected most readily on fundus autofluorescen...
PurposeA pericentral pattern of hydroxychloroquine (HCQ) retinopathy recently has been recognized in...
Background and Purpose: Occular toxicity is one of the most important complications of Hydroxychloro...
PURPOSE Hydroxychloroquine (HCQ) can cause irreversible damage to the retina, especially when taken...
Purpose The aim of this case series is to raise awareness of the emerging issue of serious retinal d...
Purpose To identify risk factors and state demographics of a cohort of patients from upper Egypt exp...
Purpose: To report an unusual fundus autofluorescence aspect in a patient with suspected hydroxychlo...
We report an unusual case of hydroxychloroquine (HCQ) toxicity after only 2 months of starting the t...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Purpose: To describe a case of hydroxychloroquine retinopathy combined with retinal pigment epitheli...
Hydroxychloroquine (HCQ; Plaquenil) is used increasingly in the management of a variety of autoimmun...
Abstract Hydroxychloroquine is widely used by rheumatologists for the treatment of various diseases,...
Hydroxychloroquine (HCQ) ocular toxicity is rare but severe, and progression can occur even after te...
Two patients with dermatological conditions developed retinal toxicity after treatment with hydroxyc...
Hydroxychloroquine (HCQ) in recent times has been used in treatment for a variety of autoimmune dise...
Retinal toxicity from hydroxychloroquine (HCQ) can be detected most readily on fundus autofluorescen...